Swiss National Bank’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.3M | Sell |
663,700
-258,800
| -28% | -$7.14M | 0.01% | 651 |
|
2025
Q1 | $26.2M | Sell |
922,500
-500
| -0.1% | -$14.2K | 0.02% | 559 |
|
2024
Q4 | $38.4M | Sell |
923,000
-43,800
| -5% | -$1.82M | 0.03% | 490 |
|
2024
Q3 | $64.6M | Buy |
966,800
+3,200
| +0.3% | +$214K | 0.04% | 363 |
|
2024
Q2 | $114M | Sell |
963,600
-7,000
| -0.7% | -$831K | 0.08% | 217 |
|
2024
Q1 | $103M | Sell |
970,600
-41,000
| -4% | -$4.37M | 0.07% | 250 |
|
2023
Q4 | $101M | Sell |
1,011,600
-30,700
| -3% | -$3.05M | 0.07% | 254 |
|
2023
Q3 | $108M | Sell |
1,042,300
-141,700
| -12% | -$14.6M | 0.08% | 227 |
|
2023
Q2 | $144M | Sell |
1,184,000
-112,000
| -9% | -$13.6M | 0.1% | 193 |
|
2023
Q1 | $199M | Sell |
1,296,000
-55,400
| -4% | -$8.51M | 0.14% | 134 |
|
2022
Q4 | $243M | Sell |
1,351,400
-113,800
| -8% | -$20.4M | 0.17% | 111 |
|
2022
Q3 | $173M | Sell |
1,465,200
-20,300
| -1% | -$2.4M | 0.12% | 152 |
|
2022
Q2 | $212M | Sell |
1,485,500
-7,200
| -0.5% | -$1.03M | 0.14% | 130 |
|
2022
Q1 | $257M | Buy |
1,492,700
+188,600
| +14% | +$32.5M | 0.15% | 126 |
|
2021
Q4 | $331M | Sell |
1,304,100
-45,400
| -3% | -$11.5M | 0.2% | 90 |
|
2021
Q3 | $519M | Buy |
1,349,500
+58,600
| +5% | +$22.6M | 0.33% | 55 |
|
2021
Q2 | $303M | Buy |
1,290,900
+144,800
| +13% | +$34M | 0.19% | 97 |
|
2021
Q1 | $150M | Buy |
1,146,100
+103,200
| +10% | +$13.5M | 0.1% | 194 |
|
2020
Q4 | $109M | Sell |
1,042,900
-16,500
| -2% | -$1.72M | 0.08% | 262 |
|
2020
Q3 | $75M | Buy |
1,059,400
+28,500
| +3% | +$2.02M | 0.06% | 315 |
|
2020
Q2 | $66.2M | Buy |
+1,030,900
| New | +$66.2M | 0.06% | 331 |
|